Biobank Participation Yields Clinical Benefits

The Mass General Brigham Biobank (formerly the Partners HealthCare Biobank) in 2019 became one of the largest collections in the nation, reaching over 100,000 participants. 

The Biobank is a collection of patient blood samples cross-referenced with our system of electronic record data. It yields invaluable medical insights, helping physicians to better understand, treat, and prevent disease. 

The Biobank is being tapped for important studies that show how genes, lifestyle, and other factors impact health and has already demonstrated value on both macro-epidemiological and individual levels. 

To date, the resource has supported more than 200 innovative research studies dealing with subjects, such as the genetic underpinnings of cardiomyopathy and predictors of Alzheimer’s disease and cancer. For an initiative that depends on volume for its success, the milestone marks a win in clinical research.